92 related articles for article (PubMed ID: 27837251)
1. MCM7 polymorphisms associated with the AML relapse and overall survival.
Lee JS; Cheong HS; Koh Y; Ahn KS; Shin HD; Yoon SS
Ann Hematol; 2017 Jan; 96(1):93-98. PubMed ID: 27837251
[TBL] [Abstract][Full Text] [Related]
2. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
3. Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.
Gotoh N; Saitoh T; Takahashi N; Kasamatsu T; Minato Y; Lobna A; Oda T; Hoshino T; Sakura T; Shimizu H; Takizawa M; Handa H; Yokohama A; Tsukamoto N; Murakami H
Int J Hematol; 2018 Sep; 108(3):246-253. PubMed ID: 29737460
[TBL] [Abstract][Full Text] [Related]
4. Modelling the Effects of MCM7 Variants, Somatic Mutations, and Clinical Features on Acute Myeloid Leukemia Susceptibility and Prognosis.
Tripon F; Iancu M; Trifa A; Crauciuc GA; Boglis A; Dima D; Lazar E; Bănescu C
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936215
[TBL] [Abstract][Full Text] [Related]
5. Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics.
Lebon D; Vergez F; Bertoli S; Harrivel V; De Botton S; Micol JB; Marolleau JP; Récher C
Leuk Res; 2015 Aug; 39(8):818-21. PubMed ID: 26002512
[TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer.
Ishibashi Y; Kinugasa T; Akagi Y; Ohchi T; Gotanda Y; Tanaka N; Fujino S; Yuge K; Kibe S; Yoshida N; Mizobe T; Oka Y; Yoshida T; Shirouzu K
Anticancer Res; 2014 Aug; 34(8):4569-75. PubMed ID: 25075101
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia.
Kunadt D; Dransfeld C; Dill C; Schmiedgen M; Kramer M; Altmann H; Röllig C; Bornhäuser M; Mahlknecht U; Schaich M; Stölzel F
Ann Hematol; 2020 Sep; 99(9):2173-2180. PubMed ID: 32621177
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
9. Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population.
Lee MK; Cheong HS; Koh Y; Ahn KS; Yoon SS; Shin HD
Genet Test Mol Biomarkers; 2016 Nov; 20(11):696-701. PubMed ID: 27610459
[TBL] [Abstract][Full Text] [Related]
10. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia].
Liu L; Yang L; Zhang Y; Xu ZF; Yu MH; Wang JX; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):378-82. PubMed ID: 18581889
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients.
Kim DH; Lee NY; Lee MH; Sohn SK; Do YR; Park JY
Br J Haematol; 2008 Jan; 140(1):71-9. PubMed ID: 17983459
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of SNP of P53 genes pathway on the adult AML patients.
Abdel Hamid TM; El Gammal MM; Eibead GT; Saber MM; Abol Elazm OM
Hematology; 2015 Jul; 20(6):328-35. PubMed ID: 25232917
[TBL] [Abstract][Full Text] [Related]
14. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
15. [The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia].
Zhang Y; Yang L; Li R; Zhang L; Zhang MR; Xiao ZJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):213-6. PubMed ID: 16624155
[TBL] [Abstract][Full Text] [Related]
16. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
[TBL] [Abstract][Full Text] [Related]
17. Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML.
Hyo Kim L; Sub Cheong H; Koh Y; Ahn KS; Lee C; Kim HL; Doo Shin H; Yoon SS
J Hum Genet; 2015 Dec; 60(12):749-54. PubMed ID: 26354033
[TBL] [Abstract][Full Text] [Related]
18. Associations of IL-10 gene polymorphisms with acute myeloid leukemia in Hunan, China.
Yao CJ; Du W; Chen HB; Xiao S; Wang CH; Fan ZL
Asian Pac J Cancer Prev; 2013; 14(4):2439-42. PubMed ID: 23725154
[TBL] [Abstract][Full Text] [Related]
19. Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase.
Falk IJ; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
Am J Hematol; 2013 Dec; 88(12):1001-6. PubMed ID: 23873772
[TBL] [Abstract][Full Text] [Related]
20. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]